Wang, J., Zuo, J., Wahafu, A., Wang, M., Li, R., & Xie, W. (2019). Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma. CNS Neurosci Ther.
Styl ChicagoWang, Jia, Jie Zuo, Alafate Wahafu, Mao‐de Wang, Rui‐chun Li, a Wan‐fu Xie. "Combined Elevation of TRIB2 and MAP3K1 Indicates Poor Prognosis and Chemoresistance to Temozolomide in Glioblastoma." CNS Neurosci Ther 2019.
Citace podle MLAWang, Jia, et al. "Combined Elevation of TRIB2 and MAP3K1 Indicates Poor Prognosis and Chemoresistance to Temozolomide in Glioblastoma." CNS Neurosci Ther 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..